← 返回

源自免疫细胞的外泌体:肿瘤免疫微环境与肿瘤治疗的新角色

英文原题:Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy.

查看英文原题

Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy.

PubMed 2022/12/21(内容时间) Int J Nanomedicine Q1 · IF 8.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

外泌体是活细胞分泌的具有典型脂质双分子层结构的小囊泡,携带多种蛋白质、脂质、RNA等重要信息,在细胞间物质和信息传递中发挥重要作用,并逐渐成为多种疾病早期诊断的标志物和药物递送系统的重要工具。免疫细胞是肿瘤微环境的重要组成部分,可通过分泌多种免疫反应性物质影响肿瘤进展。本文综述了多种免疫细胞来源的外泌体对肿瘤细胞、肿瘤微环境中不同免疫细胞及其他基质细胞的影响。不同免疫细胞来源的外泌体不仅能重塑促炎微环境以抑制肿瘤进展,还可通过抑制NK细胞、CD8+ T细胞等细胞的杀伤作用或促进肿瘤细胞及免疫抑制性免疫细胞来促进肿瘤进展。此外,我们还讨论了一些免疫细胞(如DC、M1巨噬细胞和中性粒细胞)来源的外泌体经工程化改造后发挥抑瘤作用。

展开英文摘要原文

Exosomes are small vesicles secreted by living cells, with a typical lipid bilayer structure. They carry a variety of proteins, lipids, RNA and other important information, play an important role in the transmission of substances and information between cells, and gradually become a marker for early diagnosis of many diseases and an important tool in drug delivery system. Immune cells are an important part of tumor microenvironment, and they can affect tumor progression by secreting a variety of immunoreactive substances.

This review focuses on the effects of various immune cell-derived exosomes on tumor cells, different immune cells and other stromal cells in tumor microenvironment. Exosomes derived from different immune cells can not only reshape a pro-inflammatory microenvironment to inhibit tumor progression, but also promote tumor progression by inhibiting the killing effect of NK cells, CD8 + T cells and other cells or promoting tumor cells and immunosuppressive immune cells.

In addition, we also discussed that some exosomes derived from immune cells (such as DC, M1 macrophages and neutrophils) play a tumor inhibitory role after being engineered.

论文信息

作者
Wang S、Shi Y
单位
Department of Geriatric Surgery, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.China
文献类型
综述
期刊
International journal of nanomedicine2022
原文标识
PubMed 36575698 · DOI 10.2147/IJN.S388604